Trans-perineal Trigger Point Dry Needling for Chronic Pelvic Pain

Status Completed

Clinical Trial Summary

Chronic Pelvic Pain (CPP) are around 10% of gynaecology referrals.Non-relaxing pelvic floor dysfunction (NRPFD) is an under-appreciated cause for CPP with dyspareunia where no other pathology exists. The effectiveness of manual therapy in studies have shown statistically significant pre and post treatment differences.However no study has reviewed the efficacy of inclusion of trans- perineal trigger point dry needling used with manual therapy for NRPFD. This study will investigate the effectiveness of trans-perineal trigger point dry needling used with manual therapy techniques for CPP.

Clinical Trial Description

This study will investigate the effectiveness of inclusion of trans-perineal trigger point dry needling with manual therapy treatment for chronic pelvic pain with dyspareunia and associated pelvic floor dysfunctions.The use of trigger point dry needling (TrptDN) for chronic low back pain has proved beneficial.This study will evaluate the treatment outcomes of trans-perineal trigger point dry needling and manual therapy to only manual therapy for CPP.

The outcomes will evaluate the number of treatment requirements between the dry needling with manual therapy group and the manual therapy group and review which group has faster resolution in pain and other associated pelvic floor symptoms. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02795026
Study type	Interventional
Source	Cork University Hospital
Contact
Status	Completed
Phase	N/A
Start date	April 2016
Completion date	June 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03935698` - Physiotherapy Treatment in Women With Dyspareunia Following Gynecological Cancer: a Pilot Study	N/A
Recruiting	`NCT03427255` - CBT Group Treatment for Women With Dyspareunia	N/A
Completed	`NCT02253173` - Estradiol Vaginal Softgel Capsules in Treating Symptoms of Vulvar and Vaginal Atrophy in Postmenopausal Women	Phase 3
Completed	`NCT03184077` - Rapidly Absorbing Polyglactin 910 Versus Poliglecaprone 25 for Laceration Repair	N/A
Recruiting	`NCT05445115` - The Mollie Study, a Study to Evaluate the Safety and Efficacy of the Mollie Medical Device	N/A
Withdrawn	`NCT03666819` - Carbon Dioxide Fractional Laser in Treating Participants With Stage 0-III Hormone Receptor-Positive Breast Cancer With Vulvovaginal Atrophy	Phase 2
Active, not recruiting	`NCT03681678` - Laser Therapy for Treatment of Urogenital Symptoms in Women
Completed	`NCT04955418` - Effects of Epi-no Device on Pelvic Floor Dysfunctions	N/A
Completed	`NCT05834088` - Effects of Myofascial Release With and Without Thiele Massage	N/A
Terminated	`NCT03185169` - GSM (Genitourinary Syndrome Of Menopause) Management In Breast Cancer Survivors	Early Phase 1
Completed	`NCT03307044` - Fractional CO2 Laser Therapy for Survivors of Breast Malignancies	N/A
Completed	`NCT05617820` - Study Comparing Estradiol Vaginal Inserts 4mcg To IMVEXXY ® (Estradiol Vaginal Inerts 4 mcg) In The Treatment Of Dyspareunia in Women With Vulvur and Vaginal Atrophy	Phase 3
Recruiting	`NCT03714581` - Laser Therapy Following Radiotherapy for Gynecological Cancer	N/A
Completed	`NCT04659668` - Evaluation of the Efficacy and Safety of the Dermal Filler for Female Intimate Area Hydration and Atrophy of the Vagina.	N/A
Completed	`NCT03199534` - A Trial of Pelvic Floor Chemodenervation in Patients Undergoing Physical Therapy for High Tone Pelvic Floor Dysfunction	Phase 4
Completed	`NCT00318500` - Study Evaluating the Safety and Efficacy of ERB-041 on Reduction of Symptoms Associated With Endometriosis in Reproductive-Aged Women	Phase 2
Recruiting	`NCT05540353` - Transvaginal Low-level Laser Therapy to Improve Pelvic Pain and Sexual Function in Patients With Endometriosis.	N/A
Completed	`NCT03178825` - Hybrid Fractional Laser for Symptoms of Genitourinary Syndrome of Menopause	N/A
Completed	`NCT04389489` - Postpartum Sexual Function in Pregnant Women With COVID-19
Completed	`NCT03372720` - Fractional CO2 Laser Therapy in Minimizing Genitourinary Syndrome of Menopause in Gynecological Cancer Survivors	N/A